Status:
NOT_YET_RECRUITING
The Effect of Previous Pregnancies in Patients With Gynecological Neoplasms Treated With PD-1/PD-L1 Inhibitors
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Gynecologic Cancers
Eligibility:
FEMALE
18+ years
Brief Summary
Despite the fact that immunotherapy has radically changed the therapeutic landscape in multiple types of tumors, to date the only predictive factor for response to treatment with immune checkpoint inh...
Detailed Description
In the last decade, the advent of immunotherapy has completely changed the therapeutic landscape for various diseases, leading to significant improvements in survival for patients with different condi...
Eligibility Criteria
Inclusion
- For patients past-pregnant and nulliparous:
- Age 18 years or older
- Female sex
- Confirmed cytological/histological diagnosis of endometrial or cervical cancer
- Treatment with ICI monotherapy or in combination with chemotherapy
- Written informed consent for living patients Only for patients past-pregnant:
- Available obstetric history
Exclusion
- Not eligible for treatment with ICI either in monotherapy or in combination with chemotherapy.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2030
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06945601
Start Date
May 1 2025
End Date
May 1 2030
Last Update
April 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.